[go: up one dir, main page]

ES2162929T3 - Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario. - Google Patents

Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario.

Info

Publication number
ES2162929T3
ES2162929T3 ES95925803T ES95925803T ES2162929T3 ES 2162929 T3 ES2162929 T3 ES 2162929T3 ES 95925803 T ES95925803 T ES 95925803T ES 95925803 T ES95925803 T ES 95925803T ES 2162929 T3 ES2162929 T3 ES 2162929T3
Authority
ES
Spain
Prior art keywords
azabiciclo
tetrahidro
ona
isoquinolin
benz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925803T
Other languages
English (en)
Inventor
Charles Alois Dvorak
Bruce Andrew Kowalczyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOFFMANN LA ROCHE
F Hoffmann La Roche AG
Original Assignee
HOFFMANN LA ROCHE
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2162929(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by HOFFMANN LA ROCHE, F Hoffmann La Roche AG filed Critical HOFFMANN LA ROCHE
Application granted granted Critical
Publication of ES2162929T3 publication Critical patent/ES2162929T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

TEXTO
ES95925803T 1994-07-08 1995-07-01 Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario. Expired - Lifetime ES2162929T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein

Publications (1)

Publication Number Publication Date
ES2162929T3 true ES2162929T3 (es) 2002-01-16

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925803T Expired - Lifetime ES2162929T3 (es) 1994-07-08 1995-07-01 Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario.

Country Status (16)

Country Link
US (1) US5567818A (es)
EP (1) EP0770077B1 (es)
JP (1) JP2898758B2 (es)
CN (1) CN1048727C (es)
AT (1) ATE205845T1 (es)
AU (1) AU2979995A (es)
BR (1) BR9508249A (es)
CL (2) CL2004001244A1 (es)
CY (1) CY2342B1 (es)
DE (1) DE69522808T2 (es)
DK (1) DK0770077T3 (es)
ES (1) ES2162929T3 (es)
FI (1) FI120198B (es)
MX (1) MX9700157A (es)
PT (1) PT770077E (es)
WO (1) WO1996001824A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081055A1 (en) 2000-04-20 2001-11-01 Masonite Corporation Reverse molded panel
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
EP2103612A1 (en) 2006-10-23 2009-09-23 Sicor, Inc. Crystalline forms of palonosetron hydrochloride
US20100105724A1 (en) * 2006-12-07 2010-04-29 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
EP2155199A4 (en) * 2007-05-29 2011-08-24 Chemagis Ltd NEW PALONOSETRONIC SALTS AND METHOD FOR THEIR PREPARATION AND CLEANING
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
WO2010056656A2 (en) * 2008-11-11 2010-05-20 Dr. Reddy's Laboratories Ltd. Preparation of crystalline palonosetron hydrochloride
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
CA2030718C (en) * 1989-11-28 1998-05-12 Jacob Berger Tricyclic compounds
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
CN1152313A (zh) 1997-06-18
FI120198B (fi) 2009-07-31
US5567818A (en) 1996-10-22
CL2004001244A1 (es) 2005-04-15
CN1048727C (zh) 2000-01-26
JP2898758B2 (ja) 1999-06-02
CL2007001958A1 (es) 2008-02-22
DE69522808T2 (de) 2002-04-04
WO1996001824A1 (en) 1996-01-25
BR9508249A (pt) 1998-01-06
AU2979995A (en) 1996-02-09
DE69522808D1 (de) 2001-10-25
ATE205845T1 (de) 2001-10-15
CY2342B1 (en) 2004-02-06
JPH09508645A (ja) 1997-09-02
FI970068A (fi) 1997-01-07
FI970068A0 (fi) 1997-01-07
PT770077E (pt) 2002-02-28
MX9700157A (es) 1997-04-30
EP0770077A1 (en) 1997-05-02
DK0770077T3 (da) 2002-01-14
EP0770077B1 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
PL318100A1 (en) 2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application
ES2162929T3 (es) Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario.
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
MX14663A (es) Procedimiento para la preparacion de derivados de quinazolina, producto obtenido y composicion fungicida y acaricida que lo incluye.
MX22877A (es) Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye
BR8903877A (pt) Processo para preparacao de diorganopolissiloxano linear,produto obtido e utilizacao deste produto
MX14411A (es) Procedimiento para producir 1,2-dioxetanos e intermediarios de los mismos y producto obtenido.
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
FI20011433L (fi) Menetelmä 2,5,diamino-4,6-diklooripyrimidiinin valmistamiseksi
FI971861L (fi) Puristuskoostumus, valmistusmenetelmä, puristusmenetelmä ja puristustuotteita
MX14310A (es) Procedimiento para la preparacion de nuevos agentes antiarritmicos, producto obtenido y preparacion farmaceutica que lo incluye.
MX9102864A (es) Colorantes cationicos del 1,3,4-tiadiazol y procedimiento para su obtencion.
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
ES2109103T3 (es) Procedimiento para la preparacion de trialquilsilil-7 bacatina iii.
AU630815B1 (en) New process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl) benzamide
MX11493A (es) Procedimiento para la preparacion de derivados de pirimidina y producto obtenido.
MA21805A1 (fr) Derives di - substitues des n,n'-ditrimethoxybenzoyle piperazines ainsi que leur procede de preparation .
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
MX17107A (es) Procedimiento para la preparacion de tiazolo-(1,5)-benzodiazepinas y producto obtenido
MX22522A (es) Procedimiento para la elaboracion de una composici on que contiene alfa-interferon y producto obten ido mediante el mismo.
BR9701203A (pt) Processo para a preparaçÃo de um composto de 4,6-bis-(ariloxi)-pirimidina assimétrico e composto
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
ES2174150T3 (es) Procedimiento para la obtencion de 4-hidroxianilinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 770077

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: PRODUCT NAME: PALONOSETRON (ALOXI); REG. NO/DATE: EU/1/04/306/001 20050322

Spc suppl protection certif: C200500031

Filing date: 20050610